UFPT Stock Analysis: Buy, Sell, or Hold?
UFPT - UFP Technologies Inc
$272.36
3.69 (1.37%)
▲
5d:
+7.77%
30d:
+25.87%
90d:
+40.4%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 03, 2026
29d
Get Alerted When UFPT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: UFPT is 7.7% above its trading range ($252.78). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: UFPT is 7.7% above its trading range ($252.78). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$351.98
Based on 8.3% avg growth
INTRINSIC VALUE TODAY
$218.55
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 20.3x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: UFPT is currently trading at $272.36, which is considered extended relative to its 30-day fair value range of $220.88 to $252.78. From a valuation perspective, the stock is trading at a premium (Forward PE: 23.3) compared to its historical average (20.3). At these levels, the market is pricing in 4.7% annual earnings growth. This is a high bar to clear, indicating the stock may be priced for perfection.
Technical Outlook: Technically, UFPT is in a uptrend. The price is approaching resistance at $275.19. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: UFPT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $324.50 (+19.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, UFPT is in a uptrend. The price is approaching resistance at $275.19. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: UFPT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $324.50 (+19.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$220.88 -
$252.78
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
50.0%
All Signals
- BEARISH: Price extended above range (+7.7% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($324.50)
- BEARISH: Market expects 4.7% growth - appears too optimistic based on history
Trading Range Analysis
30-Day Trading Range
$220.88 -
$252.78
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$229.87
Resistance Level
$275.20
Current Trend
Uptrend
Technical data as of
Jul 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
23.30
Wall Street Target
$324.50
(+19.1%)
Revenue Growth (YoY)
4.1%
Earnings Growth (YoY)
1.4%
Profit Margin
11.3%
Valuation Premium vs History
+4.7% premium
PE vs Historical
23.3 vs 20.3
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.7%
(market-implied from PE analysis)
1-Year Target
$285.16
(+5%)
2-Year Target
$298.56
(+10%)
3-Year Target
$312.60
(+15%)
3-Yr Target (if PE normalizes)
(PE: 23→20)
PE COMPRESSION
$272.31
(0%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 23.3, Growth: 12.5%)
$388.23
(+43%)
Base:
(SPY PE: 21.8, Growth: 12.5%)
$362.85
(+33%)
Bear:
(PE: 18.5, Growth: 12.5%)
$308.42
(+13%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (31x PE), but valuation improves significantly next year (23x PE) as earnings recover.
Trailing PE: 30.57 | Current EPS (TTM): $8.79
Bull Case
$392.96
(+44%)
Analyst growth 33.0%, PE expands to 33.6
Base Case
$357.23
(+31%)
Market implied 33.0%, PE stable at 30.6
Bear Case
$182.70
(-33%)
Severe decline -20.0%, PE contracts to 26.0
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: July 04, 2026 1:34 PM ET
Data refreshes hourly during market hours. Next update: 2:34 PM
Data refreshes hourly during market hours. Next update: 2:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is UFPT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$75 | 65 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 58 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$117 | 65 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$240 | 65 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 65 BUY |
